119 Long-term effectiveness of natalizumab for RRMS: UK and global interim results from TYSABRI observational program

Conclusions The reduction in ARR on natalizumab was similar in the TOP UK and global cohorts, including in the subset of patients with one prior DMT. These findings support the real-world effectiveness of natalizumab. Support.Biogen. Disclosures: Included on the poster. jean.vonsy@biogen.com
Source: Journal of Neurology, Neurosurgery and Psychiatry - Category: Neurosurgery Authors: Tags: Live Poster, 29 April SIG1: MS [amp ] Neuroinflammation Source Type: research